Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia. - Wikidata - awgldk - TriplyDB

Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia.

Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia.

http://www.wikidata.org/entity/Q37739015

about

Viral-specific T-cell response in hemorrhagic cystitis after haploidentical donor stem cell transplantation.

P2860

Q47656066-AD48D9FE-12F1-476C-A05C-0922BBCAA5B3

P2860

Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia.

http://www.wikidata.org/entity/Q37739015

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Dose-adapted post-transplant c ...... splantation in Fanconi anemia.

@en

Dose-adapted post-transplant c ...... splantation in Fanconi anemia.

@nl

type

label

Dose-adapted post-transplant c ...... splantation in Fanconi anemia.

@en

Dose-adapted post-transplant c ...... splantation in Fanconi anemia.

@nl

prefLabel

Dose-adapted post-transplant c ...... splantation in Fanconi anemia.

@en

Dose-adapted post-transplant c ...... splantation in Fanconi anemia.

@nl

P1433

Q37739015-974ED9C1-0150-4758-8EE3-BE4F81E998EA

P1476

Q37739015-AF728FEB-599D-4E31-8E37-BC6B087E8646

P2093

Q37739015-21CC12B6-D565-42B3-8B06-D48056520FC9

Q37739015-48B325EE-3D7C-4355-AE29-F2ED29F7F4FF

Q37739015-5BF9FFD9-1900-49A3-AD49-B929D955888A

Q37739015-875244AE-FDF3-4DD9-AC1C-E68A43484993

Q37739015-9AA24922-A9E9-4F99-AF0D-BA58E0D8BD06

Q37739015-D6F2FBC7-6B1C-42CF-8606-6B6B3D7EDBC0

Q37739015-E3C5892E-AB7A-45E0-93EC-7357221FFC75

Q37739015-F5AD0301-829F-402A-8136-CE58A26C8A48

P2860

Q37739015-30CB006C-0615-427A-9D51-99F1150B6F18

Q37739015-3831E280-116F-4164-89F0-97EAA3CD7D25

Q37739015-4F878E70-2D43-462E-8D97-2A5F8192459F

Q37739015-50051001-52CB-47AD-8310-4FC659E77ACC

Q37739015-5BFD66C2-7EBD-4AA9-B40B-6C26DA507F6D

Q37739015-606FEFFE-E4E8-426A-9DB9-3F065F8AD5CC

Q37739015-8BA47961-22AB-4454-808A-E5E9EFD214BA

Q37739015-9AC4AA1C-D68E-4598-8B07-B1104F6A24BE

Q37739015-9B2D2554-531D-4835-94BD-3CB2BC828ED5

Q37739015-9DFD2ACC-6504-4ABF-AE82-B008299F6895

P2888

Q37739015-80EB04CD-AE92-4255-B046-7F9C6F953976

P304

Q37739015-A23FABA3-50D8-4883-85E1-3A3D9DBA80BE

P31

Q37739015-3778CE46-407E-43C2-B0B6-B03F39B91C4C

P356

Q37739015-DB39C113-23D8-42EC-B95D-F32F80870B3B

P407

Q37739015-D015F41E-F21D-43A6-80CC-F120F9EB6C1E

P433

Q37739015-8E618A6D-021C-4FFB-8C95-8E8A77284D57

P478

Q37739015-C1FD354F-38B3-472A-A660-2DCFC119ED5A

P50

Q37739015-E24AA447-7423-4C8E-BAE7-B4F5F94DDFF1

P577

Q37739015-7B0A573B-A212-4CE1-A786-32A3E33F53B1

P698

Q37739015-79984AD9-A79C-474D-BA06-B502C0E4B914

P932

Q37739015-383378AA-75F6-4565-B5F0-90FB18D3AE7E

P356

P1433

Bone Marrow Transplantation

P1476

Dose-adapted post-transplant c ...... splantation in Fanconi anemia.

@en

P2093

A Woolfrey

http://www.w3.org/2001/XMLSchema#string

B M Sandmaier

http://www.w3.org/2001/XMLSchema#string

C Bonfim

http://www.w3.org/2001/XMLSchema#string

H-P Kiem

http://www.w3.org/2001/XMLSchema#string

L Burroughs

http://www.w3.org/2001/XMLSchema#string

M C Walters

http://www.w3.org/2001/XMLSchema#string

M S Thakar

http://www.w3.org/2001/XMLSchema#string

R Pasquini

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases.

Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.

Alternative donor hematopoietic cell transplantation for Fanconi anemia

HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.

Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia.

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.

Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide.

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.

P2888

P304

570-573

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2016.301

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

Rainer F. Storb

P577

2017-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28067886

http://www.w3.org/2001/XMLSchema#string

P932

5382060

http://www.w3.org/2001/XMLSchema#string